XML 117 R103.htm IDEA: XBRL DOCUMENT v3.7.0.1
Contingencies (Contingencies Narrative) (Details)
$ / shares in Units, $ in Millions
3 Months Ended
Jan. 17, 2017
USD ($)
Nov. 09, 2016
USD ($)
Mar. 31, 2017
USD ($)
item
$ / shares
Mar. 31, 2016
USD ($)
Jan. 27, 2014
USD ($)
Loss Contingencies [Line Items]          
Business Combination Contingent Consideration Arrangements, Contingent Value Right, Amount Per Share | $ / shares     $ 1.00    
Deductible related to litigation and contingent value right     $ 18.0    
Contingent value right, percentage multiplier     90.00%    
Number of contingent value rights outstanding | item     264,544,053    
Amount which CVR holders are no longer entitled to payment     $ 312.0    
Contingent value right, period payable after final resolution     60 days    
Business Combination, Contingent Consideration, Liability, Noncurrent     $ 258.0   $ 284.0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability     6.0    
Business Combination, Contingent Consideration, Liability, Current     0.0    
Pending Litigation [Member] | Legal Matters Where Negative Outcome is Known or Probable [Member]          
Loss Contingencies [Line Items]          
Legal Fees     $ 0.0 $ 1.0  
U.S. ex re. Baker vs. Community Health Systems, Inc. [Member]          
Loss Contingencies [Line Items]          
Judgment awarded   $ 1.9      
Class Action Shareholder Federal Securities Cases [Member] | Pending Litigation [Member] | Litigation Matters For Which An Outcome Cannot Be Assessed [Member]          
Loss Contingencies [Line Items]          
Number of legal cases filed | item     3    
Shareholder Derivative Actions [Member]          
Loss Contingencies [Line Items]          
Proceeds from legal settlement $ 40.0        
Shareholder Derivative Actions [Member] | Pending Litigation [Member] | Litigation Matters For Which An Outcome Cannot Be Assessed [Member]          
Loss Contingencies [Line Items]          
Number of legal cases filed | item     3